189 related articles for article (PubMed ID: 11230181)
1. WBSCR14, a gene mapping to the Williams--Beuren syndrome deleted region, is a new member of the Mlx transcription factor network.
Cairo S; Merla G; Urbinati F; Ballabio A; Reymond A
Hum Mol Genet; 2001 Mar; 10(6):617-27. PubMed ID: 11230181
[TBL] [Abstract][Full Text] [Related]
2. WBSCR14, a putative transcription factor gene deleted in Williams-Beuren syndrome: complete characterisation of the human gene and the mouse ortholog.
de Luis O; Valero MC; Jurado LA
Eur J Hum Genet; 2000 Mar; 8(3):215-22. PubMed ID: 10780788
[TBL] [Abstract][Full Text] [Related]
3. The subcellular localization of the ChoRE-binding protein, encoded by the Williams-Beuren syndrome critical region gene 14, is regulated by 14-3-3.
Merla G; Howald C; Antonarakis SE; Reymond A
Hum Mol Genet; 2004 Jul; 13(14):1505-14. PubMed ID: 15163635
[TBL] [Abstract][Full Text] [Related]
4. MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network.
Billin AN; Eilers AL; Coulter KL; Logan JS; Ayer DE
Mol Cell Biol; 2000 Dec; 20(23):8845-54. PubMed ID: 11073985
[TBL] [Abstract][Full Text] [Related]
5. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors.
Billin AN; Eilers AL; Queva C; Ayer DE
J Biol Chem; 1999 Dec; 274(51):36344-50. PubMed ID: 10593926
[TBL] [Abstract][Full Text] [Related]
6. Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?
Meroni G; Cairo S; Merla G; Messali S; Brent R; Ballabio A; Reymond A
Oncogene; 2000 Jul; 19(29):3266-77. PubMed ID: 10918583
[TBL] [Abstract][Full Text] [Related]
7. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
[TBL] [Abstract][Full Text] [Related]
8. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.
Meroni G; Reymond A; Alcalay M; Borsani G; Tanigami A; Tonlorenzi R; Lo Nigro C; Messali S; Zollo M; Ledbetter DH; Brent R; Ballabio A; Carrozzo R
EMBO J; 1997 May; 16(10):2892-906. PubMed ID: 9184233
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams-Beuren syndrome.
Tipney HJ; Hinsley TA; Brass A; Metcalfe K; Donnai D; Tassabehji M
Eur J Hum Genet; 2004 Jul; 12(7):551-60. PubMed ID: 15100712
[TBL] [Abstract][Full Text] [Related]
10. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
Hurlin PJ; Quéva C; Eisenman RN
Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
[TBL] [Abstract][Full Text] [Related]
11. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
[TBL] [Abstract][Full Text] [Related]
12. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
[TBL] [Abstract][Full Text] [Related]
13. Identification of a putative transcription factor gene (WBSCR11) that is commonly deleted in Williams-Beuren syndrome.
Osborne LR; Campbell T; Daradich A; Scherer SW; Tsui LC
Genomics; 1999 Apr; 57(2):279-84. PubMed ID: 10198167
[TBL] [Abstract][Full Text] [Related]
14. The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism.
Billin AN; Ayer DE
Curr Top Microbiol Immunol; 2006; 302():255-78. PubMed ID: 16620032
[TBL] [Abstract][Full Text] [Related]
15. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
16. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
Lafita-Navarro MC; Liaño-Pons J; Quintanilla A; Varela I; Blanco R; Ourique F; Bretones G; Aresti J; Molina E; Carroll P; Hurlin P; Romero OA; Sanchez-Céspedes M; Eisenman RN; Delgado MD; León J
J Biol Chem; 2020 Feb; 295(7):2001-2017. PubMed ID: 31919096
[TBL] [Abstract][Full Text] [Related]
17. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
Franke Y; Peoples RJ; Francke U
Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
[TBL] [Abstract][Full Text] [Related]
18. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.
Grinberg AV; Hu CD; Kerppola TK
Mol Cell Biol; 2004 May; 24(10):4294-308. PubMed ID: 15121849
[TBL] [Abstract][Full Text] [Related]
19. TBL2, a novel transducin family member in the WBS deletion: characterization of the complete sequence, genomic structure, transcriptional variants and the mouse ortholog.
Pérez Jurado LA; Wang YK; Francke U; Cruces J
Cytogenet Cell Genet; 1999; 86(3-4):277-84. PubMed ID: 10575226
[TBL] [Abstract][Full Text] [Related]
20. A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.
Tassabehji M; Carette M; Wilmot C; Donnai D; Read AP; Metcalfe K
Eur J Hum Genet; 1999; 7(7):737-47. PubMed ID: 10573005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
